Orca Bio Presents Positive Data Demonstrating the Potential

– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen in younger patients across disease control, non-relapse mortality and overall survival –– Orca-T in older patients given a reduced intensity conditioning regim...

Related Keywords

Texas , United States , American , Joshua Murray , Samer Srour , Ivan Dimov , Kelsey Grossman , Department Of Stem Cell Transplantation , Drug Administration , Corporate Communications , University Of Texas Md Anderson Cancer Center , American Society Of Hematology , Bone Marrow Transplantation Stem Cell Processing Center , Orca Bio , American Society , Annual Meeting , Older Patients , Caspian Oliai , Marrow Transplantation Stem Cell Processing , Reduced Intensity , Stem Cell Transplantation , Cellular Therapy , Regenerative Medicine Advanced Therapy ,